يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Martin, Lainie P."', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.

    المؤلفون: Richardson, Debra L, Moore, Kathleen N, Vergote, Ignace, Gilbert, Lucy, Martin, Lainie P, Mantia-Smaldone, Gina M, Castro, Cesar M, Provencher, Diane, Matulonis, Ursula A, Stec, James, Wang, Yuemei, Method, Michael, O'Malley, David M

    المصدر: Gynecol Oncol ; ISSN:1095-6859 ; Volume:185

    مصطلحات موضوعية: Antibody-drug conjugate, Clinical trial, Combination therapy, Folate receptor alpha, Mirvetuximab soravtansine, Platinum-sensitive ovarian cancer

    العلاقة: https://doi.org/10.1016/j.ygyno.2024.01.045Test; https://pubmed.ncbi.nlm.nih.gov/38447347Test

    الإتاحة: https://doi.org/10.1016/j.ygyno.2024.01.045Test
    https://pubmed.ncbi.nlm.nih.gov/38447347Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.

    المؤلفون: Martin, Lainie P.1 lainie.martin@fccc.edu, Konner, Jason A.2 konnerj@MSKCC.org, Moore, Kathleen N.3 kathleen-moore@ouhsc.edu, Seward, Shelly M.4 sseward@med.wayne.edu, Matulonis, Ursula A.5 ursula_matulonis@dfci.harvard.edu, Perez, Raymond P.6 perezonc@gmail.com, Su, Ying7 ying.su@immmunogen.com, Berkenblit, Anna7 anna.berkenblit@immunogen.com, Ruiz-Soto, Rodrigo7 rodrigo.ruizsoto@gmail.com, Birrer, Michael J.8 mbirrer@mgh.harvard.edu

    المصدر: Gynecologic Oncology. Nov2017, Vol. 147 Issue 2, p402-407. 6p.

    مصطلحات موضوعية: *JUNO protein, *PROTEIN expression, *OVARIAN epithelial cancer, *GENE targeting, *CANCER relapse, *CANCER treatment


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study.

    المؤلفون: Martin, Lainie P.1 lainie.martin@fccc.edu, Sill, Michael2, Shahin, Mark S.3, Powell, Matthew4, DiSilvestro, Paul5, Landrum, Lisa M.6, Gaillard, Stephanie L.7, Goodheart, Michael J.8, Hoffman, James9, Schilder, Russell J.10

    المصدر: Gynecologic Oncology. Mar2014, Vol. 132 Issue 3, p526-530. 5p.

    مصطلحات موضوعية: *THERAPEUTIC use of monoclonal antibodies, *OVARIAN cancer treatment, *EPITHELIAL cells, *PERITONEAL cancer, *GYNECOLOGY, *CANCER relapse, FALLOPIAN tube diseases


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer.

    المؤلفون: Moore, Kathleen N.1 kathleen-moore@ouhsc.edu, O'Malley, David M.1 David.O'Malley@osumc.edu, Vergote, Ignace1 ignace.vergote@uzleuven.be, Martin, Lainie P.1 lainie.martin@fccc.edu, Gonzalez-Martin, Antonio1 agonzalezm@seom.org, Malek, Karim1 Karim.malek@immmunogen.com, Birrer, Michael J.1 mbirrer@uab.edu

    المصدر: Gynecologic Oncology. Oct2018, Vol. 151 Issue 1, p46-52. 7p.

    مصطلحات موضوعية: *ANTINEOPLASTIC agents, *CARBOPLATIN, *OVARIAN cancer treatment, *CANCER relapse, *CANCER chemotherapy, *CANCER treatment, *THERAPEUTICS, OVARIAN cancer patients


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

    المؤلفون: Burger, Robert A.1 robert.burger@uphs.upenn.edu, Deng, Wei2 wdeng@gogstats.org, Makker, Vicky3 makkerv@mskcc.org, Collins, Yvonne4 yvonne.collins-md@advocatehealth.com, Gray, Heidi5 hgray@u.washington.edu, Debernardo, Robert6 debernr@ccf.org, Martin, Lainie P.7 lainie.martin@fccc.edu, Aghajanian, Carol3 aghajanc@MSKCC.ORG

    المصدر: Gynecologic Oncology. Sep2018, Vol. 150 Issue 3, p466-470. 5p.

    مصطلحات موضوعية: *OVARIAN cancer, *CHIMERIC proteins, *CELL-mediated cytotoxicity, *PLATINUM, *CANCER invasiveness, *THERAPEUTICS


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث